Neurotech International Ltd has released a press release.
Preclinical Success with Targeted Combination Therapies
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Story so far
Earlier from Neurotech International
- Successful Landmark Study in Paediatric ASD
- Notification regarding unquoted securities - NTI
- Neurotech International: Proposed issue of securities - NTI
- Appointment of Chief Executive Officer
- Application for quotation of securities - NTI
Later from Neurotech International
- Suspension from Official Quotation
- Extension to Voluntary Suspension
- Breakthrough results with NTI164 in paediatric asd
- Reinstatement to Official Quotation
- Q&A on NTI164 Breakthrough Clinical Trial Results in ASD
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International